deltatrials
Completed PHASE2 INTERVENTIONAL 2-arm NCT03379012

Testosterone in Metastatic Renal Cell Carcinoma Patients (FARETES)

Phase 2 Randomized Study of Efficacy and Safety of Testosterone in Metastatic Renal Cell Carcinoma Patients With Fatigue

Sponsor: Kidney Cancer Research Bureau

Conditions Metastatic Renal Cell Carcinoma
Interventions Testosterone undecanoate and sunitinib or pazopanib
Updated 7 times since 2018 Last updated: Oct 18, 2019 Started: Feb 8, 2016 Primary completion: Jan 30, 2018 Completion: Jul 30, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Metastatic Renal Cell Carcinoma, this trial is completed. The trial is conducted by Kidney Cancer Research Bureau and has accumulated 7 data snapshots since 2016. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2018 – ~Jun 2018 · 5 months · monthly snapshotRecruiting~Jun 2018 – ~Nov 2019 · 17 months · monthly snapshotRecruiting~Nov 2019 – ~Jan 2021 · 14 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

7 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  5. Nov 2019 — Jan 2021 [monthly]

    Completed PHASE2

    Status: Recruiting → Completed

▶ Show 2 earlier versions

  1. Jun 2018 — Nov 2019 [monthly]

    Recruiting PHASE2

  2. Jan 2018 — Jun 2018 [monthly]

    Recruiting PHASE2

    First recorded

Feb 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Kidney Cancer Research Bureau
Data source: Kidney Cancer Research Bureau

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations